WallStSmart
FOLD

Amicus Therapeutics Inc

NASDAQ: FOLD · HEALTHCARE · BIOTECHNOLOGY

$14.49
+0.00% today

Updated 2026-04-27

Market cap
$4.55B
P/E ratio
P/S ratio
7.17x
EPS (TTM)
$-0.09
Dividend yield
52W range
$6 – $15
Volume
3.5M

Amicus Therapeutics Inc (FOLD) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$1.78M$14.97M$64.36M$922000.00$21.43M$18.41M$363000.00$1.22M$0.00$4.96M$36.93M$91.25M$182.24M$260.89M$305.51M$329.23M$399.36M$528.29M$634.21M
Revenue growth (YoY)+739.0%+330.0%-98.6%+2224.7%-14.1%-98.0%+237.2%-100.0%+644.9%+147.1%+99.7%+43.2%+17.1%+7.8%+21.3%+32.3%+20.0%
Cost of revenue$17.69M$12.45M$10.04M$20.66M$13.34M$24.25M$20.38M$13.49M$22.39M$1.83M$833000.00$6.24M$14.40M$21.96M$31.04M$34.47M$38.60M$37.33M$52.94M$80.39M
Gross profit$1.78M$14.97M$64.36M$922000.00$21.43M$-1.97M$-13.13M$1.22M$-1.83M$4.13M$30.69M$76.84M$160.27M$229.84M$271.05M$290.63M$362.03M$475.35M$553.82M
Gross margin100.0%100.0%100.0%100.0%100.0%-10.7%-3616.8%100.0%83.2%83.1%84.2%87.9%88.1%88.7%88.3%90.7%90.0%87.3%
R&D$33.63M$31.07M$37.76M$48.08M$39.04M$50.86M$50.27M$41.94M$47.62M$76.94M$104.79M$149.31M$270.90M$286.38M$308.44M$272.05M$276.68M$152.38M$109.36M$135.84M
SG&A$28.21M$15.28M$19.67M$19.97M$15.66M$19.88M$19.36M$18.89M$20.72M$47.27M$71.15M$88.67M$127.20M$169.86M$156.41M$199.22M$214.12M$259.31M$323.38M$383.49M
Operating income$-46.86M$-45.80M$-43.96M$-7.35M$-55.84M$-50.89M$-52.93M$-64.18M$-68.70M$-130.44M$-181.89M$-441.99M$-328.78M$-304.04M$-247.00M$-206.43M$-212.12M$-77.21M$24.88M$34.49M
Operating margin-2567.5%-293.7%-11.4%-6056.2%-237.4%-287.5%-17680.7%-5612.8%-3668.6%-1196.8%-360.3%-166.8%-94.7%-67.6%-64.4%-19.3%4.7%5.4%
EBITDA$-44.70M$-44.57M$-37.64M$-4.16M$-53.76M$-46.54M$-50.24M$-61.38M$-67.01M$-128.71M$-195.14M$-428.29M$-322.47M$-332.26M$-242.98M$-202.87M$-199.58M$-92.08M$29.39M$53.81M
EBITDA margin-2498.2%-251.5%-6.5%-5830.5%-217.1%-272.9%-16909.1%-5474.5%-3935.9%-1159.7%-353.4%-182.3%-93.1%-66.4%-60.6%-23.1%5.6%8.5%
EBIT$-45.66M$-45.80M$-39.14M$-6.29M$-55.81M$-48.12M$-51.94M$-63.10M$-68.56M$-130.54M$-198.38M$-431.88M$-326.69M$-337.04M$-251.83M$-209.08M$-204.92M$-99.95M$20.84M$46.35M
Interest expense$0.00$348000.00$218000.00$278000.00$260000.00$148000.00$89000.00$46000.00$1.48M$1.58M$5.40M$17.24M$22.40M$18.87M$22.43M$32.47M$37.12M$50.15M$49.60M$46.16M
Income tax$-514363.00$351000.00$278000.00$-1.14M$-3.63M$-3.25M$-3.51M$-1.11M$1.50M$-3.74M$-165.12M$-94000.00$478000.00$2.60M$8.91M$-5.47M$1.48M$27.35M$-27.30M
Effective tax rate1.1%-0.9%0.0%-4.4%2.0%7.6%6.2%5.6%1.6%-1.1%1.8%36.8%0.0%-0.1%-0.9%-3.7%2.3%-1.0%-95.1%50.2%
Net income$-46.34M$-41.17M$-39.35M$-6.57M$-54.94M$-44.41M$-48.78M$-59.63M$-68.93M$-132.12M$-200.04M$-284.00M$-349.00M$-356.39M$-276.85M$-250.46M$-236.57M$-151.58M$-56.11M$-27.11M
Net income growth (YoY)+11.2%+4.4%+83.3%-736.5%+19.2%-9.8%-22.2%-15.6%-91.7%-51.4%-42.0%-22.9%-2.1%+22.3%+9.5%+5.5%+35.9%+63.0%+51.7%
Profit margin-2307.6%-262.9%-10.2%-5958.4%-207.2%-265.0%-16427.8%-5631.2%-4034.7%-769.0%-382.5%-195.6%-106.1%-82.0%-71.9%-38.0%-10.6%-4.3%